Search

everythinglearnresearchcommunity

for

Search:↓

High levels of 3 alpha-diol glucuronide in the blood are a marker of increased androgen action in women with excessive hair growth of unknown cause.

The conclusion is that removing both ovaries is the best treatment for excess male hormones in postmenopausal women, with medication as another option, and managing insulin resistance is important for diagnosis and treatment.

Cyproterone acetate combined with ethinyl estradiol significantly reduced hirsutism in women.

Sex steroid receptors are found in specific skin cells, affecting skin and hair functions.

Beta-sitosterol and stigmasterol might help prevent hair loss by blocking a specific enzyme.

Compound 4 is a promising treatment for hair loss with low toxicity.

Weak endocrine disruptors in mixtures can have significant effects and should be considered in risk assessments.

The normal human prostate does not significantly affect blood DHT levels.

Women with non-classic congenital adrenal hyperplasia have higher risk for heart and metabolic problems.

Hormones affect prostate health and disease, with certain hormone imbalances linked to prostate cancer and benign prostatic hyperplasia.

New compounds were made that effectively block enzymes related to prostate issues and hair loss.

Analog 23 is a promising compound for prostate cancer treatment.

A higher testosterone/dihydrotestosterone ratio in PCOS patients may indicate worse metabolic health.

Androgens like testosterone increase colon muscle contractions by affecting calcium pathways.

Early androgen exposure affects hormone receptor expression in adult female rats' brains, but not in males.

Finasteride and dutasteride are equally effective and safe for treating benign prostatic hyperplasia.

A woman's high testosterone and related symptoms were caused by overactive cells in her ovaries.

PFOS exposure disrupts hormone levels and enzyme activities in juvenile frogs, affecting males and females differently.

A new method was developed to analyze certain hormones and drugs in human blood efficiently.

Riboflavin 5′-phosphate (FMN) shows potential for treating androgen-related conditions but may be limited in treating prostate cancer.

Finasteride effectively treats enlarged prostate and male baldness, improves symptoms of hirsutism in women, but doesn't work for acne, and may delay prostate cancer progression with few side effects.

Two new compounds can block androgen receptor activity in different ways and may lead to new treatments for androgen-related diseases.

A boy's early puberty caused by a testicular tumor returned to normal after surgery.

Androgens cause oil-producing skin cells with androgen receptors to mature and produce more oil.

Testosterone can build muscle and bone without enlarging the prostate when a specific enzyme is blocked.

The MAPK/ERK pathway is crucial in controlling cell growth and death in finasteride-induced hypospadias.

Green algae can break down finasteride, reducing environmental harm.